Company Insider Tape

Arbutus Biopharma Corp insider transactions

Executive and director filing history, acquisition and disposal balance, executive concentration, cadence, and stored market context.

Symbol ABUS Latest filing 8 Jun 2026

Company Read

Acquisition-led

ABUS has 2 stored insider filings. Acquisitions account for 100.0% of classified filings and disposals account for 0.0%.

Latest filing 8 Jun 2026most recent stored row
Largest filing $0reported transaction value
Total filings 2stored transaction rows
Acquisition value $02 acquisitions
Disposal value $00 disposals
Net value $0acquisitions minus disposals

Filing cadence

Last 12 active months
Jun 2026 2

Acquisitions 100.0% · Disposals 0.0%

Jun 2026 $0

Executive concentration

By filing count
BEARDSLEY, ROBERT A Director · 1 filings
SAWHNEY, ROGER Director · 1 filings

Market Context

ABUS weekly market snapshot

Week 31 Jul 2026
Latest close 4.34 USDstored weekly close
1-week move -0.9%latest weekly bar
13-week move -10.9%medium-term context
Relative Strength -8.3Sharemaestro indicator
Fair value gap +25.3%price vs fair value
Trend signal 1smoothed trend state

Transaction History

Latest insider filings for ABUS

Showing 1-2 of 2
Date 8 Jun 2026
Insider BEARDSLEY, ROBERT ADirector
Side Acquisition
Shares 78800
Price 0.00
Value 0
Security Stock Option (Right to Buy)
Date 8 Jun 2026
Insider SAWHNEY, ROGERDirector
Side Acquisition
Shares 78800
Price 0.00
Value 0
Security Stock Option (Right to Buy)